Hexagon Capital Partners LLC Astrazeneca PLC Transaction History

Hexagon Capital Partners LLC

$546 Million
Q4 2024

A detailed history of Hexagon Capital Partners LLC transactions in Astrazeneca PLC stock. As of the latest transaction made, Hexagon Capital Partners LLC holds 3,555 shares of AZN stock, worth $258,946. This represents 0.04% of its overall portfolio holdings.

Number of Shares

3,555

Previous 4,723 24.73%

Holding current value

$258,946

Previous $368,000 36.96%

% of portfolio

0.04%

Previous 0.07%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 07, 2025	SELL	$63.2 - $79.58 $73,817 - $92,949	-1,168 Reduced 24.73%	3,555 $232,000
Q3 2024 Oct 08, 2024	BUY	$76.67 - $87.62 $2,453 - $2,803	32 Added 0.68%	4,723 $368,000
Q2 2024 Jul 12, 2024	BUY	$66.81 - $80.83 $96,674 - $116,961	1,447 Added 44.61%	4,691 $365,000
Q1 2024 Apr 18, 2024	BUY	$61.03 - $69.57 $17,881 - $20,384	293 Added 9.93%	3,244 $219,000
Q4 2023 Feb 05, 2024	BUY	$61.89 - $69.28 $70,307 - $78,702	1,136 Added 62.59%	2,951 $198,000
Q3 2023 Oct 23, 2023	SELL	$64.85 - $71.7 $18,676 - $20,649	-288 Reduced 13.69%	1,815 $122,000
Q2 2023 Jul 24, 2023	BUY	$69.91 - $75.81 $33,486 - $36,312	479 Added 29.5%	2,103 $150,000
Q1 2023 Apr 24, 2023	BUY	$63.15 - $71.6 $8,967 - $10,167	142 Added 9.58%	1,624 $112,000
Q4 2022 Jan 13, 2023	BUY	$54.21 - $70.44 $11,113 - $14,440	205 Added 16.05%	1,482 $0
Q3 2022 Oct 17, 2022	BUY	$53.02 - $135.75 $28,842 - $73,848	544 Added 74.22%	1,277 $70,000
Q2 2022 Jul 21, 2022	BUY	$59.26 - $71.14 $30,163 - $36,210	509 Added 227.23%	733 $48,000
Q4 2021 Jan 27, 2022	SELL	$54.02 - $63.83 $3,943 - $4,659	-73 Reduced 24.58%	224 $13,000
Q2 2021 Aug 11, 2021	SELL	$48.42 - $60.18 $1,743 - $2,166	-36 Reduced 10.81%	297 $18,000
Q1 2021 May 13, 2021	BUY	$47.16 - $54.44 $12,261 - $14,154	260 Added 356.16%	333 $16,000
Q4 2020 Feb 05, 2021	SELL	$48.52 - $58.02 $2,620 - $3,133	-54 Reduced 42.52%	73 $3,000
Q3 2020 Nov 10, 2020	BUY	$53.07 - $61.1 $6,739 - $7,759	127 New	127 $6,000

Others Institutions Holding AZN

# of Institutions

1,368

Shares Held

475M

Call Options Held

6.08M

Put Options Held

4.44M

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $226B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hexagon Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Hexagon Capital Partners LLC with notifications on news.

Account

Hexagon Capital Partners LLC Astrazeneca PLC Transaction History